{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:43Z","timestamp":1792782763690,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231093"],"award-info":[{"award-number":["BK20231093"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273327"],"award-info":[{"award-number":["82273327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ningbo Top Medical and Health Research Program","award":["2023010211"],"award-info":[{"award-number":["2023010211"]}]},{"name":"Zhejiang provincial medicine and health research foundation","award":["WKJ-ZJ-26087"],"award-info":[{"award-number":["WKJ-ZJ-26087"]}]},{"name":"Wu jieping medical foundation scientific research grant","award":["320.6750.2025-24-2"],"award-info":[{"award-number":["320.6750.2025-24-2"]}],"id":[{"id":"https:\/\/ror.org\/05dgwj702","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00428-026-04693-x","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:46:26Z","timestamp":1788396386000},"page":"605-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aggressive high-grade papillary-patterned renal cell carcinomas harboring FLCN mutations: expanding the clinicopathological spectrum in Birt-Hogg-Dub\u00e9 syndrome and sporadic cases"],"prefix":"10.1007","volume":"489","author":[{"given":"Xiao-tong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-bing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"12","key":"4693_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","volume":"10","author":"FH Menko","year":"2009","unstructured":"Menko FH, van Steensel MA, Giraud S et al (2009) Birt-Hogg-Dub\u00e9 syndrome: diagnosis and management. Lancet Oncol 10(12):1199\u20131206. https:\/\/doi.org\/10.1016\/S1470-2045(09)70188-3","journal-title":"Lancet Oncol"},{"issue":"12","key":"4693_CR2","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.5858\/2006-130-1865-BSCFAG","volume":"130","author":"BP Adley","year":"2006","unstructured":"Adley BP, Smith ND, Nayar R, Yang XJ (2006) Birt-Hogg-Dub\u00e9 syndrome: clinicopathologic findings and genetic alterations. Arch Pathol Lab Med 130(12):1865\u20131870. https:\/\/doi.org\/10.5858\/2006-130-1865-BSCFAG","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"4693_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrurol.2015.206","volume":"12","author":"LS Schmidt","year":"2015","unstructured":"Schmidt LS, Linehan WM (2015) Molecular genetics and clinical features of Birt-Hogg-Dub\u00e9 syndrome. Nat Rev Urol 12(10):558\u2013569. https:\/\/doi.org\/10.1038\/nrurol.2015.206","journal-title":"Nat Rev Urol"},{"issue":"4","key":"4693_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jmg-2022-109104","volume":"60","author":"FJ Bruinsma","year":"2023","unstructured":"Bruinsma FJ, Dowty JG, Win AK et al (2023) Update of penetrance estimates in Birt-Hogg-Dub\u00e9 syndrome. J Med Genet 60(4):317\u2013326. https:\/\/doi.org\/10.1136\/jmg-2022-109104","journal-title":"J Med Genet"},{"issue":"11","key":"4693_CR5","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3390\/genes13112122","volume":"13","author":"BR Webster","year":"2022","unstructured":"Webster BR, Gopal N, Ball MW (2022) Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review. Genes (Basel) 13(11):2122. https:\/\/doi.org\/10.3390\/genes13112122","journal-title":"Genes (Basel)"},{"issue":"2","key":"4693_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1535-6108(02)00104-6","volume":"2","author":"ML Nickerson","year":"2002","unstructured":"Nickerson ML, Warren MB, Toro JR et al (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub\u00e9 syndrome. Cancer Cell 2(2):157\u2013164. https:\/\/doi.org\/10.1016\/s1535-6108(02)00104-6","journal-title":"Cancer Cell"},{"key":"4693_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gene.2017.09.044","volume":"640","author":"LS Schmidt","year":"2018","unstructured":"Schmidt LS, Linehan WM (2018) FLCN: The causative gene for Birt-Hogg-Dub\u00e9 syndrome. Gene 640:28\u201342. https:\/\/doi.org\/10.1016\/j.gene.2017.09.044","journal-title":"Gene"},{"issue":"1","key":"4693_CR8","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1038\/s41467-022-34617-7","volume":"13","author":"K Asrani","year":"2022","unstructured":"Asrani K, Woo J, Mendes AA et al (2022) An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss. Nat Commun 13(1):6808. https:\/\/doi.org\/10.1038\/s41467-022-34617-7","journal-title":"Nat Commun"},{"issue":"16","key":"4693_CR9","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.3390\/cancers15164043","volume":"15","author":"P Kapur","year":"2023","unstructured":"Kapur P, Brugarolas J, Trpkov K (2023) Recent Advances in Renal Tumors with TSC\/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting. Cancers (Basel) 15(16):4043. https:\/\/doi.org\/10.3390\/cancers15164043","journal-title":"Cancers (Basel)"},{"issue":"7826","key":"4693_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano G, Di Malta C, Esposito A et al (2020) A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dub\u00e9 syndrome. Nature 585(7826):597\u2013602. https:\/\/doi.org\/10.1038\/s41586-020-2444-0","journal-title":"Nature"},{"issue":"4","key":"4693_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00428-010-0898-4","volume":"456","author":"F Petersson","year":"2010","unstructured":"Petersson F, Gatalica Z, Grossmann P et al (2010) Sporadic hybrid oncocytic\/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch 456(4):355\u2013365. https:\/\/doi.org\/10.1007\/s00428-010-0898-4","journal-title":"Virchows Arch"},{"issue":"9","key":"4693_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/PAS.0000000000002413","volume":"49","author":"P Argani","year":"2025","unstructured":"Argani P, Baraban E, Yaskiv O et al (2025) Clinically Sporadic Folliculin -mutated Renal Epithelial Neoplasms Represent a Mixture of True Somatic Folliculin-mutated and Occult Birt-Hogg-Dub\u00e9 Syndrome-associated Cases: Morphologic and Molecular Overlap With TSC\/MTOR -mutated Eosinophilic Renal Neoplasms and MiT Family Translocation Renal Cell Carcinoma. Am J Surg Pathol 49(9):859\u2013872. https:\/\/doi.org\/10.1097\/PAS.0000000000002413","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"4693_CR13","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/PAS.0000000000002435","volume":"49","author":"QY Xia","year":"2025","unstructured":"Xia QY, Wang XT, Zhang HZ et al (2025) GPNMB Expression Identifies FLCN -Associated Eosinophilic Renal Tumors With Heterogeneous Clinicopathologic Spectrum and Gene Expression Profiles. Am J Surg Pathol 49(11):1158\u20131171. https:\/\/doi.org\/10.1097\/PAS.0000000000002435","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4693_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jmg.2007.054304","volume":"45","author":"JR Toro","year":"2008","unstructured":"Toro JR, Wei MH, Glenn GM et al (2008) BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dub\u00e9 syndrome: a new series of 50 families and a review of published reports. J Med Genet 45(6):321\u2013331. https:\/\/doi.org\/10.1136\/jmg.2007.054304","journal-title":"J Med Genet"},{"issue":"1","key":"4693_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/cas.14255","volume":"111","author":"M Furuya","year":"2020","unstructured":"Furuya M, Hasumi H, Yao M, Nagashima Y (2020) Birt-Hogg-Dub\u00e9 syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrum. Cancer Sci 111(1):15\u201322. https:\/\/doi.org\/10.1111\/cas.14255","journal-title":"Cancer Sci"},{"issue":"12","key":"4693_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","volume":"26","author":"CP Pavlovich","year":"2002","unstructured":"Pavlovich CP, Walther MM, Eyler RA et al (2002) Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome. Am J Surg Pathol 26(12):1542\u20131552. https:\/\/doi.org\/10.1097\/00000478-200212000-00002","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"4693_CR17","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1097\/PAS.0000000000002305","volume":"48","author":"E Baraban","year":"2024","unstructured":"Baraban E, Fishman EK, Lafaro K et al (2024) A Confirmed Extrarenal Birt-Hogg-Dub\u00e9-Associated Oncocytic Neoplasm. Am J Surg Pathol 48(12):1624\u20131628. https:\/\/doi.org\/10.1097\/PAS.0000000000002305","journal-title":"Am J Surg Pathol"},{"key":"4693_CR18","doi-asserted-by":"publisher","unstructured":"Siegmund SE, Wobker SE, Harik LR et al (2026) Clinicopathologic characterization of renal tumors with Folliculin (FLCN) biallelic inactivation. Virchows Arch Published online May 21. https:\/\/doi.org\/10.1007\/s00428-026-04588-x","DOI":"10.1007\/s00428-026-04588-x"},{"issue":"2","key":"4693_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00428-025-04289-x","volume":"488","author":"M Zhao","year":"2026","unstructured":"Zhao M, Song J, Xu J et al (2026) FLCN-mutated eosinophilic renal tumors: clinicopathologic and molecular analysis of five cases highlighting morphologic heterogeneity. Virchows Arch 488(2):263\u2013275. https:\/\/doi.org\/10.1007\/s00428-025-04289-x","journal-title":"Virchows Arch"},{"issue":"5","key":"4693_CR20","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","volume":"173","author":"CP Pavlovich","year":"2005","unstructured":"Pavlovich CP, Grubb RL 3rd, Hurley K et al (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dub\u00e9 syndrome. J Urol 173(5):1482\u20131486. https:\/\/doi.org\/10.1097\/01.ju.0000154629.45832.30","journal-title":"J Urol"},{"issue":"3","key":"4693_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2025.03.012","volume":"88","author":"S Gupta","year":"2025","unstructured":"Gupta S, Dasari S, Warren RR et al (2025) Renal Neoplasia in Birt-Hogg-Dub\u00e9 Syndrome: Integrated Histopathologic, Bulk, and Single-cell Transcriptomic Analysis. Eur Urol 88(3):263\u2013273. https:\/\/doi.org\/10.1016\/j.eururo.2025.03.012","journal-title":"Eur Urol"},{"key":"4693_CR22","doi-asserted-by":"publisher","first-page":"105813","DOI":"10.1016\/j.humpath.2025.105813","volume":"160","author":"S Gupta","year":"2025","unstructured":"Gupta S, Dasari S, Shen W et al (2025) Morphologic and immunophenotypic characterization of conventional FLCN-mutated tumors (FMT) compared to a series of 8 non-conventional FMT. Hum Pathol 160:105813. https:\/\/doi.org\/10.1016\/j.humpath.2025.105813","journal-title":"Hum Pathol"},{"key":"4693_CR23","doi-asserted-by":"publisher","unstructured":"Gupta S, Sterner RM, Hasumi H et al (2026) A report of thirteen non-conventional FLCN-mutated (renal) tumors (FMT) and a discussion of proposed diagnostic criteria, convergent FLCN\/TFEB and FLCN\/MITF E318K signaling, and FLCN immunohistochemistry. Hum Pathol Published online June 18. https:\/\/doi.org\/10.1016\/j.humpath.2026.106205","DOI":"10.1016\/j.humpath.2026.106205"},{"issue":"9","key":"4693_CR24","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41379-018-0051-5","volume":"31","author":"XT Wang","year":"2018","unstructured":"Wang XT, Xia QY, Ye SB et al (2018) RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations. Mod Pathol 31(9):1346\u20131360. https:\/\/doi.org\/10.1038\/s41379-018-0051-5","journal-title":"Mod Pathol"},{"issue":"7","key":"4693_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/PAS.0000000000002211","volume":"48","author":"XT Wang","year":"2024","unstructured":"Wang XT, Fang R, He HY et al (2024) Recurrent Tuberous Sclerosis Complex\/Mammalian Target of Rapamycin Mutations Define Primary Renal Hemangioblastoma as a Unique Entity Distinct From Its Central Nervous System Counterpart. Am J Surg Pathol 48(7):874\u2013882. https:\/\/doi.org\/10.1097\/PAS.0000000000002211","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"4693_CR26","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-17-2310","volume":"24","author":"Z Yang","year":"2018","unstructured":"Yang Z, Yang N, Ou Q et al (2018) Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. Clin Cancer Res 24(13):3097\u20133107. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2310","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4693_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491\u2013498. https:\/\/doi.org\/10.1038\/ng.806","journal-title":"Nat Genet"},{"issue":"3","key":"4693_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE et al (2012) VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22(3):568\u2013576. https:\/\/doi.org\/10.1101\/gr.129684.111","journal-title":"Genome Res"},{"issue":"4","key":"4693_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.5470","volume":"251","author":"XT Wang","year":"2020","unstructured":"Wang XT, Fang R, Zhang RS et al (2020) Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification. J Pathol 251(4):365\u2013377. https:\/\/doi.org\/10.1002\/path.5470","journal-title":"J Pathol"},{"issue":"4","key":"4693_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/PAS.0000000000001408","volume":"44","author":"QY Xia","year":"2020","unstructured":"Xia QY, Wang XT, Fang R et al (2020) Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum. Am J Surg Pathol 44(4):477\u2013489. https:\/\/doi.org\/10.1097\/PAS.0000000000001408","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"4693_CR31","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/PAS.0000000000000502","volume":"39","author":"Q Rao","year":"2015","unstructured":"Rao Q, Shen Q, Xia QY et al (2015) PSF\/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. Am J Surg Pathol 39(9):1181\u20131196. https:\/\/doi.org\/10.1097\/PAS.0000000000000502","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4693_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/PAS.0000000000002458","volume":"50","author":"M Zhang","year":"2026","unstructured":"Zhang M, Xian J, Tang J et al (2026) Clinicopathologic and Molecular Study of TFEB -altered Renal Cell Carcinomas: Tumors With Frequent PDL1 Expression. Am J Surg Pathol 50(1):84\u2013102. https:\/\/doi.org\/10.1097\/PAS.0000000000002458","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"4693_CR33","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/modpathol.2017.24","volume":"30","author":"S Gupta","year":"2017","unstructured":"Gupta S, Johnson SH, Vasmatzis G et al (2017) TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Mod Pathol 30(7):998\u20131012. https:\/\/doi.org\/10.1038\/modpathol.2017.24","journal-title":"Mod Pathol"},{"issue":"7","key":"4693_CR34","first-page":"1392","volume":"6","author":"QY Xia","year":"2013","unstructured":"Xia QY, Rao Q, Shen Q et al (2013) Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features. Int J Clin Exp Pathol 6(7):1392\u20131399","journal-title":"Int J Clin Exp Pathol"},{"key":"4693_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-014-0163-z","volume":"9","author":"PR Benusiglio","year":"2014","unstructured":"Benusiglio PR, Giraud S, Deveaux S et al (2014) Renal cell tumour characteristics in patients with the Birt-Hogg-Dub\u00e9 cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis 9:163. https:\/\/doi.org\/10.1186\/s13023-014-0163-z","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"4693_CR36","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/bjc.2011.463","volume":"105","author":"AC Houweling","year":"2011","unstructured":"Houweling AC, Gijezen LM, Jonker MA et al (2011) Renal cancer and pneumothorax risk in Birt-Hogg-Dub\u00e9 syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Br J Cancer 105(12):1912\u20131919. https:\/\/doi.org\/10.1038\/bjc.2011.463","journal-title":"Br J Cancer"},{"key":"4693_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cancergen.2025.01.007","volume":"292\u2013293","author":"MG Evans","year":"2025","unstructured":"Evans MG, Thomas LW, Nakasaki M et al (2025) Clinical and genetic characteristics in two cases of Birt-Hogg-Dub\u00e9 syndrome associated with papillary renal cell carcinoma and rare Folliculin (FLCN) variants. Cancer Genet 292\u2013293:65\u201368. https:\/\/doi.org\/10.1016\/j.cancergen.2025.01.007","journal-title":"Cancer Genet"},{"issue":"5","key":"4693_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/path.2139","volume":"211","author":"T Murakami","year":"2007","unstructured":"Murakami T, Sano F, Huang Y et al (2007) Identification and characterization of Birt-Hogg-Dub\u00e9 associated renal carcinoma. J Pathol 211(5):524\u2013531. https:\/\/doi.org\/10.1002\/path.2139","journal-title":"J Pathol"},{"issue":"12","key":"4693_CR39","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/jmg.39.12.906","volume":"39","author":"SK Khoo","year":"2002","unstructured":"Khoo SK, Giraud S, Kahnoski K et al (2002) Clinical and genetic studies of Birt-Hogg-Dub\u00e9 syndrome. J Med Genet 39(12):906\u2013912. https:\/\/doi.org\/10.1136\/jmg.39.12.906","journal-title":"J Med Genet"},{"issue":"3","key":"4693_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cas.12601","volume":"106","author":"M Furuya","year":"2015","unstructured":"Furuya M, Hong SB, Tanaka R et al (2015) Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dub\u00e9 syndrome. Cancer Sci 106(3):315\u2013323. https:\/\/doi.org\/10.1111\/cas.12601","journal-title":"Cancer Sci"},{"issue":"7","key":"4693_CR41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/gcc.20663","volume":"48","author":"TA Koski","year":"2009","unstructured":"Koski TA, Lehtonen HJ, Jee KJ et al (2009) Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer. Genes Chromosomes Cancer 48(7):544\u2013551. https:\/\/doi.org\/10.1002\/gcc.20663","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"4693_CR42","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1158\/1078-0432.CCR-20-3788","volume":"27","author":"G Sun","year":"2021","unstructured":"Sun G, Zhang X, Liang J et al (2021) Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma. Clin Cancer Res 27(6):1734\u20131743. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3788","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4693_CR43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.clindermatol.2022.07.014","volume":"40","author":"RR Shah","year":"2022","unstructured":"Shah RR, Lambert WC, Schwartz RA (2022) Birt-Hogg-Dub\u00e9 syndrome: Another mTOR phenomenon. Clin Dermatol 40(6):700\u2013705. https:\/\/doi.org\/10.1016\/j.clindermatol.2022.07.014","journal-title":"Clin Dermatol"},{"issue":"5","key":"4693_CR44","doi-asserted-by":"publisher","first-page":"e16877","DOI":"10.15252\/emmm.202216877","volume":"15","author":"C Di Malta","year":"2023","unstructured":"Di Malta C, Zampelli A, Granieri L et al (2023) TFEB and TFE3 drive kidney cystogenesis and tumorigenesis. EMBO Mol Med 15(5):e16877. https:\/\/doi.org\/10.15252\/emmm.202216877","journal-title":"EMBO Mol Med"},{"issue":"12","key":"4693_CR45","doi-asserted-by":"publisher","first-page":"e15793","DOI":"10.1371\/journal.pone.0015793","volume":"5","author":"SB Hong","year":"2010","unstructured":"Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM (2010) Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS ONE 5(12):e15793. https:\/\/doi.org\/10.1371\/journal.pone.0015793","journal-title":"PLoS ONE"},{"issue":"1","key":"4693_CR46","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41467-023-44229-4","volume":"15","author":"N Alesi","year":"2024","unstructured":"Alesi N, Khabibullin D, Rosenthal DM et al (2024) TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex. Nat Commun 15(1):406. https:\/\/doi.org\/10.1038\/s41467-023-44229-4","journal-title":"Nat Commun"},{"issue":"2","key":"4693_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/path.5875","volume":"257","author":"DC Salles","year":"2022","unstructured":"Salles DC, Asrani K, Woo J et al (2022) GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms. J Pathol 257(2):158\u2013171. https:\/\/doi.org\/10.1002\/path.5875","journal-title":"J Pathol"},{"issue":"11","key":"4693_CR48","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1097\/PAS.0000000000002117","volume":"47","author":"H Li","year":"2023","unstructured":"Li H, Argani P, Halper-Stromberg E et al (2023) Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1\/2\/MTOR Alterations From Others. Am J Surg Pathol 47(11):1267\u20131273. https:\/\/doi.org\/10.1097\/PAS.0000000000002117","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4693_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/PAS.0000000000002152","volume":"48","author":"XM Wang","year":"2024","unstructured":"Wang XM, Mannan R, Zhang Y et al (2024) Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dub\u00e9 Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT. Am J Surg Pathol 48(2):163\u2013173. https:\/\/doi.org\/10.1097\/PAS.0000000000002152","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04693-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04693-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04693-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:23:32Z","timestamp":1789550612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04693-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4693"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04693-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki. This study was approved by the Institutional Review Boards Committee of the authors\u2019 institutions.","order":1,"name":"Ethics","label":"Compliance with ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","label":"Disclosure<b>\/conflict of Interest<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}]}}